Thus, activated lung CD8+ TRM cells might strategically regulate the induction of IFN-γ and type I interferon in a temporal manner, thus allowing them to leverage different properties of the two IFN types at different phase of infection to inhibit the virus while limiting the inflammation-caused lung damage. The gene discussed is CD8A; the disease is infection.